Abstract
Ovarian cancer is the leading cause of death from reproductive disorders (Clark & Matassarin, 1993) . In 2000, there were 2,500 women diagnosed with ovarian cancer and 1,500 who died from their disease (NCIC, 2000) . Seventy-five per cent of women who have ovarian cancer are diagnosed with advanced (stage III or IV) disease (Young, 1995) and, as with other cancers, prognosis is linked to the stage of disease and gradient of tumour at diagnosis. Ovarian cancer has been described as a silent predator of unsuspecting women. Its vague symptoms and the paucity of empirical research about the disease confound its diagnosis and management. Late diagnosis has limited the understanding of the course of the disease. Ovarian cancer and its treatment also may have considerable effect on a woman and her family. It often has a prolonged and variable course characterized by initial response to antineoplastic therapies, followed by relapse and progression of disease.
At present, little is known about the experiences of women who are living with ovarian cancer. Existing research tends to focus on describing symptoms (Montazeri, McEwen, & Gillis, 1996; , including psychosocial distress (Kornblith et al., 1995) , or measuring quality of life with standardized scales (Guidozzi, 1993; Roberts, Rossetti, Cone, & Cavanagh, 1992; Zacharias, Gilag, & Foxall, 1994) and standardized interviews or surveys (Dawson, 1993; Fitch, Gray, DePetrillo, Franssen, & Howell, 1999; Powel, 1998) . These studies have shown relatively consistent findings: marked anxiety and depression have been observed in many women; sexuality is often negatively influenced; social functioning is impaired, especially as it relates to the ability to work; and physical functioning and disease progression are often predictive of changes in quality of life. Symptoms such as fatigue, pain, and psychological distress are most prevalent in this population (Portenoy, Thaler et al., 1994) . Additionally, studies often focus on gynecologic cancer, but may not report findings specific to ovarian cancer patients (Cain et al., 1983; Roberts et al.) .
Few studies have utilized qualitative approaches to describe the viewpoints of women about living with ovarian cancer (Ersek, Ferrell, Dow & Melancon, 1997) . Allchin-Petardi (1998) used a sample of women with ovarian cancer to test Parse's theory of human becoming. Interviews with eight women focused on overcoming hardship and uncovered three core concepts: deliberately persisting, significant engagements, and shifting life patterns. Payne (1990) utilized open-ended interviews to explore ovarian cancer patients' coping with chemotherapy. Four predominant coping styles emerged from her analysis: think positive/fighter, acceptance, fearfulness, and hopelessness.
The purpose of this study was to describe the experiences of women living with ovarian cancer. It was anticipated that by understanding their viewpoints regarding their experiences during diagnosis, treatment, and follow-up care, insight could be gained for improvements in care delivery, as well as identifying ideas for future research.
Background on ovarian cancer
The majority of ovarian cancers are epithelial tumours, although others are adenocarcinomas or evolve from germ or stromal cells. Symptoms of ovarian cancer include abdominal distention, urinary frequency and urgency, pleural effusion, malnutrition, and pain from pressure caused by tumour growth. The patient may also complain of effects of urinary or bowel obstruction, constipation, ascites with dyspnea, and eventually generalized, severe pain. The appearance of symptoms is usually indicative of pressure on surrounding CONJ • 12/3/02 RCSIO • 12/3/02 organs and metastasis to fallopian tubes, uterus, and ligaments. By the time symptoms appear, disease is likely already widespread. Tumour cells have travelled to distant organs via pelvic blood vessels, resulting in lymph and blood involvement and peritoneal seeding.
The risk factors associated with ovarian cancer are age over 40 years; family history; nulliparity; infertility; history of heavy menstrual bleeding; dysmenorrhea; North American or Northern European ethnicity; health history of endometrial, colon, or breast cancer; and hereditary ovarian cancer syndromes (Clark & Matassarin, 1993; Lee, 2000) . Pregnancy, breast-feeding, tubal ligation, hysterectomy, and oral contraceptive use appear to lower a woman's risk of developing ovarian cancer. Other studies have tried, albeit unsuccessfully, to determine a relationship between ovarian cancer with diet and/or perineal talc exposure (Health Canada, 1999) .
Diagnostic tests for ovarian cancer include bimanual pelvic examination, transvaginal ultrasound, and CA-125 (blood sample) testing. Combining these three investigations improves the chances of finding an early stage ovarian cancer in women at risk. However, lack of evidence of test effectiveness makes each of these strategies problematic and the need for evidence-based guidelines in this area has been identified (Gray, Chart, Carroll, Fitch, & Cloutier-Fisher, 1999) .
Treatment for ovarian cancer usually includes surgery, chemotherapy, and/or radiation. A total abdominal hysterectomy, bilateral salpingo-oophrectomy with omenectomy, and debulking of the tumour are done initially to stage the tumour, confirm the diagnosis, and remove as much of the tumour as possible. Radiation treatments and various combinations of chemotherapy agents are given in an attempt to diminish symptoms, delay recurrence, and improve survival rates. To date, hormone treatment and immunotherapy offer little benefit over standard chemotherapy regimes. A combination of platinum chemotherapy consisting of cisplatin and carboplatin and/or taxol is the first line chemotherapy of choice in Canada. Although this standard treatment for chemotherapy provides a 70 to 80% response rate, long-term survival rates remain poor (Balat et al., 1996) .
Purpose of the study
The purpose of the study was to describe the experiences of women with ovarian cancer during their diagnostic, treatment, and follow-up care periods. The interview approach allowed the women to talk about the topics that were of importance to them.
Methods
The study sample consisted of 18 women who were interviewed regarding their experiences with ovarian cancer. Women were identified through nurses and gynecologic oncologists in two major cancer centres. The criteria for participation included: 1) ovarian cancer diagnosis, 2) able to speak English, and 3) able to talk about their experiences. The nurses and oncologists invited the women to participate in the interview. An invitation to participate was also extended in a letter to the local ovarian cancer support group. Potential participants were asked to give permission for the nurse researcher to receive their names and telephone numbers. The research nurse called interested women to explain the purpose of the study in detail and to schedule an interview at a convenient time. Women were informed that neither participation in the study nor refusal to participate would in any way affect their care. Information about the ethical issues, including confidentiality and the reporting of aggregated data, was given before a verbal consent was obtained over the telephone from each woman. The study was approved by the ethics committee of Sunnybrook and Women's College Health Sciences Centre.
The interviews, lasting about an hour, were conducted over the telephone and audiotaped. Telephone interviews were used because of convenience for the participants and study budget restrictions on travel for the interviewer. The individual who conducted all the interviews was a Master's-prepared nurse with a high level of skill in this type of work (KD).
A semi-structured interview guide was used to conduct the interviews. The questions served as a stimulus to help the woman tell about her experiences during diagnosis, treatment, and followup care. The participants were asked to talk about what had happened to them regarding their ovarian cancer from the time they were first aware something was different about their bodies to the time of the interview. The interviewer listened as the woman shared her experiences, and also probed for the following topics if the participant did not volunteer the information: making therapy choices, obtaining information, involvement in decision-making, living with the impact of the illness, changes in lifestyle, and obtaining supportive care services. These probes were developed on the basis of issues that had been previously described in the literature as key issues for breast cancer patients . Demographic information (i.e., age, marital status, length of time since diagnosis, number of children, education, and current work status) was gathered to provide a description of the participants.
Interview data were transcribed verbatim and all 18 interviews were read by three of the authors (MF, KD, DH). Working together and comparing impressions of each woman's story, these three authors designed a coding category scheme for the data. This scheme facilitated the organization of the data into content categories. Data were coded by one author (KD) according to the categories developed by the three authors. The overall category scheme did not change during the course of the coding. Finally, the data in each content category were reviewed by the authors and themes were developed to reflect the broad ideas shared by the women.
During the analysis, it became apparent that there was a wealth of information contained in the interviews. To do justice to the data, the team decided to write several articles to share the findings of this work. This article will focus on the perspectives women shared about the peridiagnostic period. Subsequent articles by the authors will discuss findings from this study concerning women's experiences undergoing treatment, confronting the emotional impact of this disease, and dealing with recurrence.
Findings
Two themes related to the peridiagnostic interval emerged from the findings. The two themes are the focus of this article and are described in detail. Quotes have been used to illustrate the perspectives women have shared. Pseudonyms are used in the text.
Sample
Eighteen women were interviewed about their experience with ovarian cancer. The mean age for the sample was 53.2 years (range of 35 to 73). The mode for the time since diagnosis was five months. More than half of the sample (n=12) had been diagnosed in the 12 months prior to the interview. The remaining women were between 13 months and 12 years postdiagnosis.
Twelve women in the sample were married and six were without a partner, being either single, separated, divorced, or widowed. Six women in the sample did not have any children, while 12 had between one and four children. Two women completed primary school education, six completed secondary school, seven attended university, and three attained college diplomas. Eight women did not work outside the home by choice or because of retirement at the time of the interview. Six women were on long-term disability from their jobs. Four women had returned to work on a part-time or full-time basis after their diagnosis and initial course of treatment.
Theme one: Getting the definitive diagnosis was a long and winding path
The women in this study often described the process of symptom assessment as a long and winding path before a definitive diagnosis was made. The vague symptoms of ovarian cancer were frequently unrecognized as warning signs by the women themselves and by health professionals. The women confused symptoms and physical complaints with normal body changes they thought were related to childbearing or menopause, or dismissed the symptoms as being caused by other stressful situations in the woman's life. In any case, women did not think the symptoms were important enough to pursue.
Looking In this sample, five women did not have symptoms. Their ovarian cancer was diagnosed through incidental testing for issues such as fertility or after elective surgery for medical conditions. The other 13 women experienced physical symptoms including bloating, gastrointestinal symptoms, fatigue, sexual problems, and eventually pain. However, when they sought assistance, most of these symptoms were attributed to gastrointestinal problems or menopause and were not generally investigated until the symptom of pain was experienced. about their bodies. For some, that learning was acute at the time of diagnosis, while for others it was more pointed after treatment had finished, and emerged as they thought back over their experience. Many indicated a desire to pass this lesson on to other women.
Don't dismiss something (symptom) and don't let your doctor tell you that just because you're a woman you're going to experience these things. Everything is not to be put down to menopause or PMS or anything else. [Jane]
Theme two: Communication with health care professionals was confusing and difficult Looking back, the women felt that they had little access to information during the diagnostic interval or at the time of the initial diagnosis. Information about ovarian cancer and its risks was not readily available.
Communication with health professionals during the diagnostic interval was at times confusing and difficult, especially for women experiencing symptoms without a definitive diagnosis. Women were uncomfortable physically, and emotionally they were filled with anxiety about their health concerns.
.
..they (doctors) still didn't tell me anything but the day before the surgery a doctor, a woman doctor... she sat down on my bed and said, "Well, you probably have cancer and this is what they're going to do and they're going to take out everything." And I said "everything!" ... I said "even my cervix?" And she said, "Oh yeah, they'll take out everything." And I said to her "well, won't I get all loose and won't everything fall down?" And she said, "Oh no, they'll just bolt the ligaments together. And you'll lose your sex drive and you'll dry up." And this is a woman doctor! [Gail]
The women in the study were frustrated when health professionals did not always listen to the women's intuitive concerns and instead remained focused on one specific body system.
At some point actually I can recall talking to my doctor on the phone and saying, "Could this be something to do with my ovaries?" And her saying, "No, we're definitely in the right system, you know, the symptoms are all gastrointestinal." And I have absolutely no idea why I thought that! You know, I didn't even know where my ovaries were, but it just came out of my mouth.
[Susan] They expressed disappointment with health professionals' behaviours in that they felt some of the health professionals were hesitant and not forthright with information about the diagnosis.
And The language used by health professionals was sometimes confusing and not familiar to patients and their family members. Patients were left to assume and interpret the medical jargon on their own. Participants wondered if the health professionals actually knew the answers to their questions or were avoiding issues patients raised.
Well 
Discussion
This article presents the perspectives of women living with ovarian cancer regarding the peridiagnostic period. The peridiagnostic period is an important one to investigate, given the evidence that early detection decreases mortality for most cancers (Wikborn, Pettersson, & Moberg, 1996) . The open-ended interviews in this study allowed the women to share their perspectives surrounding the recognition, identification, and investigation of symptoms prior to learning they had ovarian cancer. The findings provide insight regarding delay in diagnosis of ovarian cancer that has implications for practice.
Factors associated with diagnostic delay have been described by various investigators, often classifying them as patient factors, physician factors, and health care system factors (Diagnosis Working Group, 2000) . Patient delay involves the time it takes a patient to seek help once a symptom has been discovered, while physician and system delay involve the time it takes for a patient to be evaluated, diagnosed, and treated once help has been sought (Caplan & Helzlsouer, 1992) . Furthermore, patient delay has been conceptualized as including an appraisal delay (process of symptom interpretation), illness delay (time between a person concluding he or she is ill and deciding to seek medical help), behavioral delay (time between making a decision to seek help and making an appointment), and scheduling delay (time between making the appointment and receiving the medical attention) (Andersen, Cacioppo, & Roberts, 1995) .
Studies about the reasons for diagnostic delay have reported large variations in the proportion of the delays that are attributed to the patient. For example, in recent work with breast cancer patients, the delay was attributed by the woman herself to the patient in about 25% of the cases (Caplan, Helzlsouer, Shapiro, Wesley, & Edwards. 1996) . The most common reason given was that the women felt the problem was not important. In about 45% of the cases, the provider and the health care system were said to be responsible for the delay through difficulties in scheduling or physician inaction. Studies of esophagogastric cancer revealed estimates that patients accounted for 29% to 80% of the delays (Martin, Young, Sue-Ling, & Johnston, 1997; Schmidt, 1997) . Lack of knowledge on the patient's part was cited most frequently as the reason for the delays. A similar picture is painted with the findings of this present study. Women spoke about their lack of knowledge regarding the symptoms they were experiencing and having no idea the symptoms could herald cancer. Not realizing their importance, women did not take action immediately upon noticing changes.
The situation with ovarian cancer is also compounded in that the symptoms are rather vague and mimic other gastric disorders, some of which are self-limiting and not lifethreatening. Deciding to seek medical advice can be a complex decision in light of such an uncertain situation. According to Carter and Winslet (1998) , there are many reasons why a patient may not actually call a physician: the symptom is not deemed serious enough, it is too unpleasant or embarrassing, a wait-and-see policy is adopted, investigation is feared, the cause is already known, a serious underlying condition is suspected, there may be an association with a dietary indiscretion, a lack of faith in physicians, or a lack of time to consult a physician. According to Hackett and his colleagues (Hackett, Cassem, & Raker, 1973) , what eventually sent patients to seek medical assistance was pain, incapacity, fear, advice from a friend or relative, or attending a routine medical check-up. For the women in this present study, many adopted a wait-and-see approach. They perceived their symptoms as the result of ageing, menopause, or eating something that did not agree with them. In retrospect, many reported they would have acted sooner if they had realized the potential seriousness of the symptoms. Andersen and her colleagues have developed a conceptual model to explain patient delay (Andersen et al., 1995) . Their research supports the hypothesis that the appraisal of symptoms or the interpretation of their importance accounts for the major portion of patient delay. Designing interventions aimed at shortening this delay needs to begin by understanding the patients' perceptions during the appraisal process. This current study lends support to that conceptual model. The women with ovarian cancer were aware of their symptoms, but did not assign enough importance to them to seek help immediately. Furthermore, when they did mention the symptoms to their physicians, they tended not to receive feedback initially that would have significantly changed their perceptions.
Once the women in this study realized that the symptoms were not resolving or were becoming more bothersome, they did seek medical advice. The subsequent process of symptom assessment was perceived as long, winding, and fraught with frustration and increasing concern about their health. Responses from the medical community seemed vague and unconcerned. Such descriptions have been reported in other studies, especially where cancer was suspected. The interval of waiting for a diagnostic test result is perceived by individuals as endless, anxiety-provoking, and filled with uncertainty and a pervasive sense of helplessness (Benedict, Williams, & Baron, 1994; DeGrasse, Hugo, & Plotnikokk, 1997; Fitch et al., 2000; Northouse, Jeffs, Cracchiolo-Caraway, Lampman, & Dorris, 1995; Risberg, Sorbye, Norum & Wist, 1996) . It is a time of heightened psychosocial distress (Benedict et al.; Jones & Greenwood, 1994) which is increasingly aggravated the longer the period of delay (Risberg et al.) . Receiving a definitive diagnosis at least places the individual in a position of knowing what has to be faced.
The women in this study described symptoms that are typical of the clinical presentation of ovarian cancer (Goff, Mandel, Muntz, & Melancon, 2000) . These symptoms do mimic common inflammatory gastrointestinal disease, despite the reality that the symptoms could also herald widespread ovarian cancer. This makes diagnosis of ovarian cancer a complex clinical process (Wikborn et al., 1996) . The standard process of differential diagnosis supports the approach of ruling out the most common explanation for the symptoms as an initial step. However, as these women reflected back upon the process of being investigated, they expressed dismay at the length of time they felt it took physicians to focus on ovarian cancer as a possible explanation for their symptoms. They felt time had been lost with pursuit of other needless investigations.
Physician and system delay in diagnosis are increasingly of concern in our health care system. Goff et al. (2000) reported factors that were significantly associated with delay in diagnosis of ovarian cancer included omission of pelvic examination on the first visit; having a multitude of symptoms; being diagnosed initially as having no problem, depression, stress, irritable bowel, or gastritis; not initially receiving ultrasound, computed tomography, or CA-125 test; and younger age. Additionally, a recent survey of Canadian family physicians revealed considerable variation in their knowledge of the risk factors for ovarian cancer .
Of particular concern, however, is the women's perspectives that they were not heard when they voiced their fears or shared their symptoms. They perceived their concerns were dismissed. This type of communication added frustration to a situation already filled with uncertainty. Many felt they had to be more than assertive to have their concerns addressed. They harboured an inner conviction that something was wrong with their body, yet they received little support for that conviction from health care professionals. This type of interaction can easily undermine a relationship between a patient and health care professional.
At the time of the interview, the women in this study still carried a sense of anger about the communication process between themselves and the physicians involved in the peridiagnostic period. The perspectives about communication shared by the women in this study raise questions about the skills health care professionals have in being sensitive and responsive to patients' needs in the midst of increasing patient loads and decreasing resources in clinical settings. Similar communication issues have also been reported by breast cancer patients and led to the development of special communication programs (Parboosingh & Inhaber, 1998) . Creative solutions are also needed to overcome this communication barrier for ovarian cancer patients during the peridiagnostic period.
Implications for education, research and practice
The findings from this study have implications, firstly, for public education. Given that so many women did not have an awareness about the risk factors and symptoms of ovarian cancer, there could be benefit from the development of public education materials to inform women about these matters. There is also a clear need for the development of better screening tests for the identification of ovarian cancer at an early stage. Having a definitive test could preclude the seemingly lengthy process of symptom assessment women currently undergo.
In terms of nursing practice, implications arise from this study in several areas. Firstly, nurses need to be aware of the risk factors and symptoms of ovarian cancer and share that information with their female patients. Nurses who work in community health settings and physician offices are in ideal positions for such education with well women. Nurses in any setting who are aware their patients have potential risk factors for ovarian cancer may wish to have a focused discussion about it with those women. The discussion could focus on being aware of bodily changes, interpreting the importance of those changes, and taking appropriate action.
Secondly, nurses need to pay particular attention to the descriptions of any changes a woman is experiencing, particularly bloating, weight gain around her stomach, alterations in bowel or bladder function, indigestion, or pelvic pain. Nurses could play a role in supporting the woman and helping her interpret the importance of the symptoms. While the woman is undergoing investigation, nurses could help her understand and prepare for test procedures, and set expectations for what will be learned from the test results and when the results will be available. Nurses can be advocates for scheduling tests and reporting findings in a timely manner. Recognizing that the peridiagnostic period is a time of high stress, nurses need to be assessing when an individual could benefit from referral to counselling. Ensuring women have contact information for relevant agencies where women could obtain information would also be important. Particularly for ovarian cancer, the Cancer Information Services (1-888-939-3333) and the National Ovarian Cancer Association (1-877-413-7970) could be valuable resources.
Finally, in terms of communication, nurses have a role to play in fostering therapeutic exchange. Nurses need to be aware of how patients are perceiving the behaviours of health care professionals and whether the women feel the professionals are hearing and attending to their voiced concerns. Patients may need to learn about the health care system and the process for making a diagnosis so they can understand what is happening to them, why they are undergoing the specific diagnostic procedures, and what kind of timelines to expect. In particular, the nurse caring for the woman at the time she learns of her diagnosis needs to be aware of the impact of that diagnosis and be sensitive to that individual's perspective. Even though a definitive diagnosis may herald the end of uncertainty about what is wrong, it marks the beginning of the uncertainty about treatment and its impact. 
